Jul 28, 2011
By:
Amy Ritter
The age of globalized industry should result in fewer barriers between countries, but in practice it is rarely that straightforward, according to a report by ScienceInsider.
|
Jul 21, 2011
By:
Amy Ritter
A bill introduced by Senators Scott Brown (R-MA), Ron Wyden (D-OR), and John McCain (R-AZ) on July 13, 2011, aims to encourage states to reduce Medicaid spending by offering financial incentives to substitute generic drugs for branded ones where possible.
|
Jul 14, 2011
By:
Amy Ritter
Recent trends in the US biopharmaceutical industry suggest this is a pivotal area for potential job creation.
|
Jul 7, 2011
By:
Amy Ritter
Members of the House Energy and Commerce Committee are expanding their investigation into the 2008 entry of contaminated heparin from China into the United States market.
|
Jul 7, 2011
By:
Amy Ritter
FDA issued a draft guidance, entitled "Q11 Development and Manufacture of Drug Substances," which is now available for comment according to a notice published on June 29, 2011, in the Federal Register.
|
Jun 23, 2011
By:
Amy Ritter
A subsidiary of Johnson & Johnson initiated a voluntary recall of its antipsychotic medication, Risperdal, due to an unusual odor.
|
Jun 16, 2011
By:
Amy Ritter
An FDA guidance has provided information for products that involve the application of nanotechnology, and rationales for those points.
|
Jun 9, 2011
By:
Amy Ritter
A South Carolina court found that a subsidiary of Johnson & Johnson violated state consumer protection laws by using misleading marketing for its antipsychotic drug, Risperdal.
|
|
More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.
Jun 2, 2011
By:
Amy Ritter
More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.
|
|
